Total Returns (Price + Dividend) 
Nephrocare Healt for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Oct-2026 | Source : BSEWe are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for quarter ended 30th September 2026 received from M/s. KFIN Technologies Limited.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
28-Sep-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Polar Capital Funds PLC
Closure of Trading Window
25-Sep-2026 | Source : BSETrading window shall be closed till 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter and half yearly ended September 30 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 9 Schemes (3.2%)
Held by 17 FIIs (8.78%)
Edoras Investment Holdings Pte Ltd (28.3%)
Investcorp India Investments Holding Limited (6.29%)
5.7%
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 3.68% vs 2.28% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 15.34% vs 28.88% in Mar 2026
Annual Results Snapshot (Standalone) - Mar'26
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period